By Devika Patel
Knoxville, Tenn., Dec. 7 – Medical Transcription Billing Corp. placing another $3.89 million of its 11% series A cumulative redeemable perpetual preferred stock (Nasdaq: MTBCP) via a best-efforts offering, according to a prospectus filed with the Securities and Exchange Commission.
H.C. Wainwright & Co. is the placement agent. Boenning & Scattergood, Inc. is co-placement agent.
The preferreds will be sold at par of $25.00 per share. The last reported sale price of the series A preferreds was $25.10 on Dec. 6.
Dividends are payable on the 15th day of each month. The preferreds become redeemable on Nov. 4, 2020 at par plus accrued dividends.
The preferreds are also redeemable upon a change of control.
Proceeds from the latest preferreds will be used for working capital, organic growth initiatives and general corporate purposes.
The company has previously issued multiple tranches of the 11% preferred shares. After this current offering, there will be 1,084,739 shares, or about $27.12 million, of the preferreds outstanding.
Medical Transcription is a Somerset, N.J.-based health care information technology company.
| Issuer: | Medical Transcription Billing, Corp.
|
|
|
| Securities: | Series A cumulative redeemable perpetual preferred stock
|
|
|
| Amount: | $3,886,000, or 155,440 shares
|
|
|
| Maturity: | Perpetual
|
|
|
| Placement agent: | H.C. Wainwright & Co.,
|
|
|
| Co-placement agent: | Boenning & Scattergood, Inc.
|
|
|
| Dividend: | 11%, payable monthly
|
|
|
| Price: | Par of $25.00
|
|
|
| Call option: | After Nov. 4, 2020 at par and upon a change of control
|
|
|
| Pricing date: | Dec. 7
|
|
|
| Stock symbol: | Nasdaq: MTBCP
|
|
|
| Stock price: | $25.10 at close Dec. 6
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
